1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Anal Incontinence Global Clinical Trials Review, H1, 2015

Anal Incontinence Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Anal Incontinence Global Clinical Trials Review, H1, 2015" provides data on the Anal Incontinence clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anal Incontinence. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anal Incontinence. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Anal Incontinence Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Anal Incontinence 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Anal Incontinence to Gastrointestinal Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Anal Incontinence 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Anal Incontinence Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
S.L.A. Pharma AG 26
Clinical Trial Overview of S.L.A. Pharma AG 26
RDD Pharma Ltd. 27
Clinical Trial Overview of RDD Pharma Ltd. 27
Laboratoire HRA Pharma 28
Clinical Trial Overview of Laboratoire HRA Pharma 28
Clinical Trial Overview of Top Institutes / Government 29
Centre Hospitalier Universitaire - Hopitaux de Rouen 29
Clinical Trial Overview of Centre Hospitalier Universitaire - Hopitaux de Rouen 29
Bezirkskrankenhaus Schwaz 30
Clinical Trial Overview of Bezirkskrankenhaus Schwaz 30
Dalhousie University 31
Clinical Trial Overview of Dalhousie University 31
Herlev Hospital 32
Clinical Trial Overview of Herlev Hospital 32
Pontificia Universidad Catolica de Chile 33
Clinical Trial Overview of Pontificia Universidad Catolica de Chile 33
Uppsala University Hospital 34
Clinical Trial Overview of Uppsala University Hospital 34
Five Key Clinical Profiles 35
Appendix 47
Abbreviations 47
Definitions 47
Research Methodology 48
Secondary Research 48
About GlobalData 49
Contact Us 49
Disclaimer 49
Source 49

List of Tables
Anal Incontinence Therapeutics, Global, Clinical Trials by Region, 2015* 6
Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 9
Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2015* 10
Anal Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 11
Anal Incontinence Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 12
Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13
Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Anal Incontinence Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Anal Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Anal Incontinence Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by S.L.A. Pharma AG, 2015* 26
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by RDD Pharma Ltd., 2015* 27
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire HRA Pharma, 2015* 28
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire - Hopitaux de Rouen, 2015* 29
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezirkskrankenhaus Schwaz, 2015* 30
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Dalhousie University, 2015* 31
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Herlev Hospital, 2015* 32
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Pontificia Universidad Catolica de Chile, 2015* 33
Anal Incontinence Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University Hospital, 2015* 34

List of Figures
Anal Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Anal Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Anal Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 9
Anal Incontinence Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 10
Proportion of Anal Incontinence to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 13
Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Anal Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Anal Incontinence Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Anal Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Anal Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Anal Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Anal Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Anal Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Anal Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Anal Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 48

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.